COVID-19 Research

March 26, 2020

No items found.

‍Research funding opportunities related to COVID-19

On behalf of the Department of Health and Social Care, NIHR has established a single national process to prioritise and coordinate funding for COVID-19 research. This applies across all funded studies including public sector, industry and charity funding.

Information about this can be found here

Details of the process and the new single entry point can be found here

Application form is here

‍

UKRI Open Call – Research and innovation ideas to address COVID-19

IMI2 - Call 21 Development of therapuetics and diagnostics combatting coronavirus infections (closes 31 March 2020)

DASA COVID-19 Rapid sanitising technology for ambulances (closes 1st April 2020)

‍TechForce19 Supporting the elderley, vulnerable and self-isolating during COVID-19 (closes 1 April 2000)

LifeArc COVID-19 Development and testing of therapeutics (closes 6th April 2020)

Innovate UK Business-led innovation in response to global disruption (de minimis) (closes 17 April)

BSAC COVID-19 Supporting research projects (closes 17 April, simple application)

COVID-19 Therapeutics Accelerator Bill & Melinda Gates Foundation, Mastercard, Wellcome - contact: epidemics@wellcome.ac.uk for more infomation

Wellcome: Epidemic Preparedness COVID-19 (reviewing current proposals, may reopen)

‍

Are you researching COVID-19?

We love what all of our clients do. And we're always impressed by those working to tackle health care problems and save lives

So, at the moment we offer a FREE R&D Tax Credit Service for one year for organisations researching ways to tackle COVID-19 and its effects

We can also offer support with:

Identifying appropriate government support for your business
Bringing your year end forward so that you can file your R&D Tax Claim sooner
Free 1-2-1 support via the Innovate2succeed Programme
Plus a comprehensive range of other business support services
‍

‍Business Support Information

We've collated this list of links for businesses during this time

‍

We're here for an informal chat if you want to talk any of this through - just contact us using the details below

Call us on 01925 506100
Email us at info@inventya.com

Thanks for all that you're doing

‍

Image used in the header for this item:

Novel Coronavirus SARS-CoV-2. SEM showing SARS-CoV-2 (orange)—also known as 2019-nCoV, the virus that causes COVID-19 emerging from the surface of cells (green) cultured in the lab.
Credit: NIAID-RML

Downloaded from here cropped to size

‍

March 26, 2020

← back to news

Consultancy

Bid Writing

Thank you! We will be in touch shortly.

Oops! Something went wrong while submitting the form.

Your privacy matters | View our privacy policy

More of our news

How SMEs Can Leverage the UK Government’s Sustainability Agenda for Growth

The UK government’s renewed focus on sustainability presents SMEs with an unprecedented opportunity to grow and thrive. From access to capital and job creation to simplified regulations and consumer demand for eco-friendly products, there are numerous ways SMEs can benefit from the government’s sustainability agenda.

September 11, 2024

Inspiring Innovation here in Wigan Borough

Start-up businesses, entrepreneurs and innovators of Wigan Borough - it’s time to get inspired. A support service tailored to your needs and circumstances is on offer through a Wigan Council scheme and could take your enterprise to the next level.The Inspiring Innovation programme launched earlier this year, funded by the UK Shared Prosperity Fund (UKSPF), and dozens of businesses – from start-ups through to established firms - are already signed up.

August 30, 2024

Maxine Adam Joins Inventya Board as Non-Executive Director

We are delighted to welcome Maxine to our board," stated Aldo De Leonibus, CEO of Inventya. "Her expertise in business growth and innovation will be a tremendous asset as we continue to support our clients in navigating the complexities of scaling and achieving sustainable growth. Maxine's proven track record and deep understanding of the innovation ecosystem will enhance our strategic direction and client offerings.

August 27, 2024

Choosing the Right European Funding Instrument: EIC Accelerator vs. EIC Pathfinder

Both the EIC Accelerator and EIC Pathfinder are great opportunities for companies and researchers, with the ultimate goal of fostering innovation within the European Union. By understanding the unique features and purposes of each funding instrument, you can strategically choose the one that aligns best with your project's stage, goals, and funding requirements. Leveraging these instruments effectively can accelerate your journey from groundbreaking research to market leadership. Shape

August 14, 2024

3 Top Tips When Scaling Your Business

As your business grows, maintaining efficiency becomes critical. Streamline processes, automate where possible, and ensure your operations can handle increased volume without compromising quality. Key actions include

June 13, 2024

Simplify CRM with Bigin by Zoho: The Ultimate CRM Solution for R&D-Focused Small Businesses

At Inventya, we can be your partners in implementing Bigin into your operations, setting your team up with a system tailored to your bespoke business needs while ensuring scalability with your business growth. In essence, our Zoho and digital growth experts will guide you through effective implementation, leaving your team to concentrate on what it does best.

May 23, 2024

R&D Tax Credits

Scale Up

Grant Funding

Consultancy

Scale Up

Scale Up

Scale Up

Scale Up

Commercial Partnerships

Bid Writing

Enterprise Europe Network

Innovate UK

R&D Tax Credits

Scale Up

Grant Funding

Consultancy

Commercial Partnerships

Bid Writing

Enterprise Europe Network

Innovate UK

COVID-19 Research

March 26, 2020

‍Research funding opportunities related to COVID-19

Are you researching COVID-19?

So, at the moment we offer a FREE R&D Tax Credit Service for one year for organisations researching ways to tackle COVID-19 and its effects

Image used in the header for this item:

Novel Coronavirus SARS-CoV-2. SEM showing SARS-CoV-2 (orange)—also known as 2019-nCoV, the virus that causes COVID-19 emerging from the surface of cells (green) cultured in the lab. Credit: NIAID-RML

Downloaded from here cropped to size

More of our news

The latest funding, scale up and business growth tips, straight to your inbox

Commercial Services

Innovate UK Business Growth (previously Innovate UK EDGE)

Contact

Social Links

Other

Novel Coronavirus SARS-CoV-2. SEM showing SARS-CoV-2 (orange)—also known as 2019-nCoV, the virus that causes COVID-19 emerging from the surface of cells (green) cultured in the lab.
Credit: NIAID-RML